Universitätsklinikum Regensburg

Cancer survivorship in malignant melanoma Langzeit-Krebsüberleben (Survivorship) beim malignen Melanom (2026) Reitmajer M, Dugas-Breit S, Blomen CL, Livingstone E, Schlaak M, Heppt M, Sachse MM, et al. Journal article An international multicenter cohort study of management and outcomes of undescended testis in German-speaking countries (2026) Aubert O, Föller J, Beume JS, Brinkmann O, Degener S, Drießler C, Eckoldt F, et al. Journal article Adjuvant systemic therapy for melanoma in clinical practice: A multicenter study at 51 DeCOG skin cancer centers Adjuvante Systemtherapie beim Melanom in der Praxis: Multizentrische Erhebung an 51 DeCOG-Hautkrebszentren (2026) Reitmajer M, Livingstone E, Heinzerling L, Thoms KM, Meiss F, Heppt M, Gesierich A, et al. Journal article Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗ (2026) Butz E, Steinbrenner I, Schultheiss UT, Behning C, Binder H, Hansmann H, Gronwald W, et al. Journal article S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Genetisch-cholestatische Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2026) Hudert CA, Jankofsky M, Keitel-Anselmino V, Krawczyk M, Kremer A, Lammert F, Lurz E, et al. Journal article Anti-BAFF treatment modulates intragraft fibrosis and DKK3 expression in a non-adherence model of experimental kidney transplantation (2026) Preiss A, Daniel C, Vonbrunn E, Scharf M, Banas B, Bergler T, Schuster A Journal article Multi-Centric Quality Analysis of Oncological Data in FHIR (2026) Fischer C, Gulden C, Quell D, Ziegler J, Hellwig D, Ganslandt T, Pukrop T, Pallaoro P Journal article Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of Gluconate (2026) Harrer DC, Haferkamp S, Herr W, Mycielska M, Dörrie J, Schaft N, Abken H, Drexler K Journal article Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial (2026) Hörner M, Tretschock LM, John N, Ziegler P, Häberle L, Uhrig S, Goossens C, et al. Journal article Comparison of the Prognostic Value of Three Different Single HLA Based Antibody Detection Assays (2026) Heinemann FM, Hallensleben M, Althaus K, Budde K, Einecke G, Eisenberger U, Ender A, et al. Journal article